Patients should stop taking fluoroquinolone antibiotics at the first sign of tendon pain, avoid exercise and contact their doctor, the FDA said. The FDA would only say that it has received "hundreds" of reports of tendon problems linked to fluoroquinolones, without being more specific, citing the ongoing lawsuit. Cipro is one of the drugs for which the FDA will require a "black box" label warning about tendon problems. Cox said the FDA would not require companies to send letters to doctors alerting them about the connection between tendon problems and the antibiotics. "We are troubled that the FDA is not doing everything within its power to prevent more people from needlessly suffering disabling tendon ruptures.